BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25167922)

  • 1. A selenosemicarbazone complex with copper efficiently down-regulates the 90-kDa heat shock protein HSP90AA1 and its client proteins in cancer cells.
    Shen H; Zhu H; Song M; Tian Y; Huang Y; Zheng H; Cao R; Lin J; Bi Z; Zhong W
    BMC Cancer; 2014 Aug; 14():629. PubMed ID: 25167922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
    Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
    Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of the pathogen receptor HSP90AA1 to avibirnavirus VP2 induces autophagy by inactivating the AKT-MTOR pathway.
    Hu B; Zhang Y; Jia L; Wu H; Fan C; Sun Y; Ye C; Liao M; Zhou J
    Autophagy; 2015; 11(3):503-15. PubMed ID: 25714412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
    Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
    Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paeoniflorin protects against cisplatin-induced acute kidney injury through targeting Hsp90AA1-Akt protein-protein interaction.
    Zhang MY; Ma LJ; Jiang L; Gao L; Wang X; Huang YB; Qi XM; Wu YG; Liu XQ
    J Ethnopharmacol; 2023 Jun; 310():116422. PubMed ID: 36972781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma.
    Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z
    J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of survival and chemoresistance by HSP90AA1 in ovarian cancer SKOV3 cells.
    Chu SH; Liu YW; Zhang L; Liu B; Li L; Shi JZ; Li L
    Mol Biol Rep; 2013 Jan; 40(1):1-6. PubMed ID: 23135731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic analysis reveals that heat shock protein 90α is a potential diagnostic and prognostic biomarker for cancer.
    Chen W; Li G; Peng J; Dai W; Su Q; He Y
    Eur J Cancer Prev; 2020 Jul; 29(4):357-364. PubMed ID: 31567483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting PI3K/Akt/HSP90 signaling sensitizes gastric cancer cells to deoxycholate-induced apoptosis.
    Redlak MJ; Miller TA
    Dig Dis Sci; 2011 Feb; 56(2):323-9. PubMed ID: 20585984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the MAPK11/12/13/14 (p38 MAPK) pathway regulates the transcription of autophagy genes in response to oxidative stress induced by a novel copper complex in HeLa cells.
    Zhong W; Zhu H; Sheng F; Tian Y; Zhou J; Chen Y; Li S; Lin J
    Autophagy; 2014 Jul; 10(7):1285-300. PubMed ID: 24905917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models.
    Jensen MR; Schoepfer J; Radimerski T; Massey A; Guy CT; Brueggen J; Quadt C; Buckler A; Cozens R; Drysdale MJ; Garcia-Echeverria C; Chène P
    Breast Cancer Res; 2008; 10(2):R33. PubMed ID: 18430202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative and Apoptotic Role of Novel Synthesized Cu(II) Complex with 3-(3-(4-fluorophenyl)Triaz-1-en-1-yl) Benzenesulfonamide in Common Cancer Models.
    Tuluce Y; Gorgisen G; Gulacar IM; Koyuncu I; Durgun M; Akocak S; Ozkol H; Kaya Z
    Anticancer Res; 2018 Sep; 38(9):5115-5120. PubMed ID: 30194157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Semi-Synthetic Cu (II)-Cardamonin Complex Exerts Potent Anticancer Activity against Triple-Negative Breast and Pancreatic Cancer Cells via Inhibition of the Akt Signaling Pathway.
    Hossan MS; Break MKB; Bradshaw TD; Collins HM; Wiart C; Khoo TJ; Alafnan A
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33918814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganetespib induces G2/M cell cycle arrest and apoptosis in gastric cancer cells through targeting of receptor tyrosine kinase signaling.
    Lee H; Saini N; Parris AB; Zhao M; Yang X
    Int J Oncol; 2017 Sep; 51(3):967-974. PubMed ID: 28713919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNX-2112, a novel Hsp90 inhibitor, induces G2/M cell cycle arrest and apoptosis in MCF-7 cells.
    Wang SX; Ju HQ; Liu KS; Zhang JX; Wang X; Xiang YF; Wang R; Liu JY; Liu QY; Xia M; Xing GW; Liu Z; Wang YF
    Biosci Biotechnol Biochem; 2011; 75(8):1540-5. PubMed ID: 21821931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiosemicarbazone(s)-anchored water soluble mono- and bimetallic Cu(ii) complexes: enzyme-like activities, biomolecular interactions, anticancer property and real-time live cytotoxicity.
    Balakrishnan N; Haribabu J; Dhanabalan AK; Swaminathan S; Sun S; Dibwe DF; Bhuvanesh N; Awale S; Karvembu R
    Dalton Trans; 2020 Jul; 49(27):9411-9424. PubMed ID: 32589180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative effect of HSP90 inhibitor Y306zh against pancreatic cancer is mediated by interruption of AKT and MAPK signaling pathways.
    Xue N; Jin J; Liu D; Yan R; Zhang S; Yu X; Chen X
    Curr Cancer Drug Targets; 2014; 14(7):671-83. PubMed ID: 25219422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors.
    Breinig M; Mayer P; Harjung A; Goeppert B; Malz M; Penzel R; Neumann O; Hartmann A; Dienemann H; Giaccone G; Schirmacher P; Kern MA; Chiosis G; Rieker RJ
    Clin Cancer Res; 2011 Apr; 17(8):2237-49. PubMed ID: 21372220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90.
    Lundgren K; Zhang H; Brekken J; Huser N; Powell RE; Timple N; Busch DJ; Neely L; Sensintaffar JL; Yang YC; McKenzie A; Friedman J; Scannevin R; Kamal A; Hong K; Kasibhatla SR; Boehm MF; Burrows FJ
    Mol Cancer Ther; 2009 Apr; 8(4):921-9. PubMed ID: 19372565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of the Tumor Cell Growth Inhibitory Potential of New Putative HSP90 Inhibitors.
    Bizarro A; Sousa D; Lima RT; Musso L; Cincinelli R; Zuco V; De Cesare M; Dallavalle S; Vasconcelos MH
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29438315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.